Invesco UK Ltd Invesco Ltd: Form 8.3 - Amgen Inc
02 Décembre 2022 - 12:59PM
UK Regulatory
TIDMIRSH
FORM 8.3
IRISH TAKEOVER PANEL
OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF
THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES
REPRESENTING 1% OR MORE
1. KEY INFORMATION
(a) Full name of discloser Invesco Ltd.
---------------------------------------------------------------------- -------------------------
(b) Owner or controller of interests and short positions
disclosed, if different from 1(a)
The naming of nominee or vehicle companies is insufficient.
For a trust, the trustee(s), settlor and beneficiaries
must be named.
---------------------------------------------------------------------- -------------------------
(c) Name of offeror/offeree in relation to whose relevant Amgen Inc
securities this form relates
Use a separate form for each offeror/offeree
---------------------------------------------------------------------- -------------------------
(d) If an exempt fund manager connected with an offeror/offeree,
state this and specify identity of offeror/offeree
(Note 1)
---------------------------------------------------------------------- -------------------------
(e) Date position held/dealing undertaken 01/12/2022
For an opening position disclosure, state the latest
practicable date prior to the disclosure
---------------------------------------------------------------------- -------------------------
(f) In addition to the company in 1(c) above, is the YES
discloser also making disclosures in respect of any If YES, specify which:
other party to the offer? Horizon Therapeutics PLC
If it is a cash offer or possible cash offer, state
"N/A"
---------------------------------------------------------------------- -------------------------
2. INTERESTS AND SHORT POSITIONS
If there are interests and short positions to disclose in more
than one class of relevant securities of the offeror or offeree
named in 1(c), copy table 2 for each additional class of relevant
security.
Interests and short positions in the relevant securities of the
offeror or offeree to which the disclosure relates following the
dealing (if any) (Note 2)
Class of relevant security
(Note 3) Common Stock US0311621009
-------------------------------------------------------- -------------------------------
Short
Interests positions
-------------------------------------------------------- ------------------ -----------
Number % Number %
-------------------------------------------------------- ---------- ------ ------ ---
(1) Relevant securities owned and/or controlled 10,450,086 1.958
-------------------------------------------------------- ---------- ------ ------ ---
(2) Cash-settled derivatives
-------------------------------------------------------- ---------- ------ ------ ---
(3) Stock-settled derivatives (including options)
and agreements to purchase/ sell
-------------------------------------------------------- ---------- ------ ------ ---
Total 10,450,086 1.958
-------------------------------------------------------- ---------- ------ ------ ---
All interests and all short positions should be disclosed.
Details of options including rights to subscribe for new
securities and any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8.
3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(c), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchase/sale Number of Price per unit
security securities (Note 5)
----------------- ------------- ----------- --------------
Common Stock Sale 29,851 286.40 USD
----------------- ------------- ----------- --------------
Common Stock Sale 6 284.58 USD
----------------- ------------- ----------- --------------
Common Stock Sale 5 286.40 USD
----------------- ------------- ----------- --------------
Common Stock Purchase 13,589 286.40 USD
----------------- ------------- ----------- --------------
Common Stock Purchase 20 288.00 USD
----------------- ------------- ----------- --------------
Common Stock Purchase 3 285.94 USD
----------------- ------------- ----------- --------------
(b) Cash-settled derivative transactions
Class of Product Nature of dealing Number of Price
relevant description e.g. opening/ closing a long/ short position, increasing/ reference per unit
security e.g. CFD reducing a long/ short position securities (Note 5)
(Note 6)
--------- ------------ ---------------------------------------------------------- ----------- ---------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, purchasing, selling, varying Number Exercise Type Expiry Option
relevant description e.g. call etc. of price per e.g. date money
security option securities unit American, paid/
to which European received per unit
option etc.
relates
(Note 6)
--------- ---------------------- ------------------------------------- ----------- ---------- ---------- ------ ------------------
(ii) Exercise
Class of Product Exercising/ Number of Exercise
relevant description exercised securities price per
security e.g. call against unit
option (Note 5)
--------- ------------ ----------- ----------- ----------
(d) Other dealings (including transactions in respect of new securities) (Note 3)
Class of Nature of dealing Details Price per unit (if
relevant e.g. subscription, applicable)
security conversion, exercise (Note 5)
--------- --------------------- ------- ------------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement,
or any agreement or understanding, formal
or informal, relating to relevant securities
which may be an inducement to deal or
refrain from dealing entered into by
the person making the disclosure and
any party to the offer or any person
acting in concert with a party to the
offer.
Irrevocable commitments and letters
of intent should not be included. If
there are no such agreements, arrangements
or understandings, state "none"
-----------------------------------------------
(b) Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement
or understanding between the person
disclosing and any other person relating
to the voting rights of any relevant
securities under any option referred
to on this form or relating to the voting
rights or future acquisition or disposal
of any relevant securities to which
any derivative referred to on this form
is referenced. If none, this should
be stated.
------------------------------------------
(c) Attachments
Is a Supplemental Form 8 attached? NO
----------------------------------
Date of disclosure 02/12/2022
------------------- ---------------
Contact name Philippa Holmes
------------------- ---------------
Telephone number 01491 417447
------------------- ---------------
Public disclosures under Rule 8.3 of the Rules must be made to a
Regulatory Information Service.
(END) Dow Jones Newswires
December 02, 2022 06:59 ET (11:59 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
Invesco (LSE:0UAN)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Invesco (LSE:0UAN)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
